PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
27-Jun-2025 Course of Gubra A/S' Extraordinary General Meeting Regarding Extraordinary Dividend ACCESS Newswire
27-Jun-2025 Pharmaceutical Drug Delivery Market Estimated at USD 2.15 Trillion in 2025, to Expand 77% by 2035 MARKITWIRED
27-Jun-2025 In Vitro Fertilization Market Valued at USD 819.8M in 2024, to Double by 2034 MARKITWIRED
27-Jun-2025 Molecular Quality Controls Market Poised to Hit USD 452.6 Million by 2035 MARKITWIRED
27-Jun-2025 Vaccines Market to Reach USD 4.02 Billion by 2035, Growing at 5.9% CAGR MARKITWIRED
27-Jun-2025 Organ Preservation Market USD 455M by 2032 at 6.4% CAGR MARKITWIRED
27-Jun-2025 Interventional Radiology Market USD 30.3B in 2025 to USD 49.4B in 2035 MARKITWIRED
27-Jun-2025 Acetaminophen Market Projected to Hit USD 16.33 Billion by 2035 MARKITWIRED
27-Jun-2025 Antibody Therapy Market Set to Reach USD 1,059.7 Billion by 2035 MARKITWIRED
27-Jun-2025 Glaucoma Treatment Market in 2025 Expected to Hit USD 8.5 Billion by 2035 MARKITWIRED
27-Jun-2025 ePharmacy Market to Reach USD 439.7 Billion by 2035, Growing at 13.8% CAGR MARKITWIRED
27-Jun-2025 Cell Culture Media Market Valued at USD 3.5 Billion in 2024 MARKITWIRED
27-Jun-2025 Chromatography Software Market to Hit USD 3.9 Billion by 2035, Growing at 11.1% CAGR MARKITWIRED
27-Jun-2025 Ear Health Market to Reach USD 3.6 Billion by 2035, Growing at 6.6% CAGR MARKITWIRED
27-Jun-2025 Cleanroom Technologies Market to USD 15.88 Billion by 2035 MARKITWIRED
27-Jun-2025 Stroke Catheters Market Toward USD 2.05 Billion by 2035 MARKITWIRED
27-Jun-2025 Biovica International AB - Annual Report for the Financial Year 2024/2025 Published ACCESS Newswire
26-Jun-2025 Revolutionizing Clinical Trials: Evolution Summit 2025 Returns to San Diego Marcus Evans
26-Jun-2025 eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing ACCESS Newswire
26-Jun-2025 Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share Dermapharm Holding SE